UPDATED May 21, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
688408 | CN¥101.57 | -3.5% | 40.0% | CN¥13.7b | CN¥89.23 | PE29.7x | E24.5% | 0.9% | Capital Goods | ||
HHR | AU$0.008 | 14.3% | -69.2% | AU$22.5m | n/a | PE7.6x | E86.3% | n/a | Energy | ||
A178320 | ₩25,800.00 | -1.9% | 57.0% | ₩1.4t | ₩34,500.00 | PE133.6x | E48.1% | 0% | Tech | ||
A179900 | ₩37,550.00 | -0.7% | 66.9% | ₩594.1b | ₩60,000.00 | PS30.7x | E111.6% | 0% | Tech | ||
CTT | AU$2.49 | -17.8% | 14.2% | AU$1.0b | AU$4.26 | PE49x | E29.9% | n/a | Retail | ||
A080160 | ₩15,770.00 | -3.0% | -10.1% | ₩278.4b | ₩18,500.00 | PE61x | E45.6% | 1.6% | Consumer Services | ||
A067310 | ₩24,000.00 | -11.6% | 38.6% | ₩1.1t | ₩36,000.00 | PS1.2x | E67.2% | 0.2% | Semiconductors | ||
ACI | ₹619.55 | -4.1% | 15.2% | ₹76.5b | ₹738.00 | PE24x | E29.0% | 0.3% | Materials | ||
3029 | CN¥26.99 | 7.0% | -6.0% | CN¥5.3b | n/a | PS12.8x | E69.2% | 0% | Software | ||
KEBNI B | kr1.51 | 2.9% | 24.1% | kr410.5m | kr2.20 | PS4.5x | E90.4% | n/a | Tech | ||
ELABS | kr16.70 | 6.6% | 44.5% | kr1.8b | kr25.00 | PS25.6x | E124.6% | n/a | Software | ||
NOHAL | kr23.00 | 3.6% | -12.2% | kr899.4m | kr32.50 | PS8.8x | E90.7% | n/a | Food, Beverage & Tobacco | ||
EH | US$16.47 | -9.1% | 46.5% | US$1.1b | US$26.84 | PS48.1x | E104.9% | n/a | Capital Goods | ||
VOW | kr5.80 | -7.2% | -54.0% | kr660.3m | kr11.00 | PB1.7x | E99.3% | 0% | Commercial Services | ||
CALTX | kr116.00 | -5.5% | 12.6% | kr6.2b | kr208.00 | PS5.2x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
GIG | kr30.50 | -4.4% | 11.1% | kr4.0b | kr45.03 | PE18.8x | E36.2% | n/a | Consumer Services | ||
OSE | €7.26 | 0.6% | 100.0% | €157.6m | €7.15 | PS70.8x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
FDE | €38.30 | 2.3% | -10.1% | €200.3m | €64.07 | PE25.5x | E37.6% | n/a | Energy | ||
ADOC | €9.17 | -0.3% | 168.9% | €132.0m | €9.70 | PS21.8x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
300827 | CN¥26.77 | -3.5% | -23.3% | CN¥9.6b | CN¥39.25 | PE31.9x | E39.8% | 0.4% | Capital Goods | ||
532900 | ₹69.11 | 10.2% | 168.9% | ₹62.1b | ₹87.50 | PE34.7x | E27.8% | 0.1% | Diversified Financials | ||
603786 | CN¥73.18 | 0.3% | 32.7% | CN¥29.4b | CN¥85.91 | PE42.2x | E25.1% | 0.8% | Automobiles | ||
688639 | CN¥112.84 | -5.4% | -0.4% | CN¥17.7b | CN¥135.72 | PE39x | E28.5% | 0.8% | Materials | ||
2707 | CN¥6.79 | 5.8% | -10.5% | CN¥6.7b | CN¥7.73 | PE68.2x | E33.1% | 0% | Consumer Services |